lysine has been researched along with ADDH in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lintermans, B; Rondou, P; Skieterska, K; Van Craenenbroeck, K | 1 |
| Biederman, J; Findling, RL; Krishnan, S; McGough, JJ; Zhang, Y | 1 |
1 trial(s) available for lysine and ADDH
| Article | Year |
|---|---|
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Lisdexamfetamine Dimesylate; Lysine; Male; Treatment Outcome | 2007 |
1 other study(ies) available for lysine and ADDH
| Article | Year |
|---|---|
KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 Variant.
Topics: Adaptor Proteins, Signal Transducing; Attention Deficit Disorder with Hyperactivity; Cell Line; Genotype; HEK293 Cells; Humans; Lysine; Microfilament Proteins; Polymorphism, Genetic; Receptors, Dopamine D4; Ubiquitination | 2015 |